Filing Details

Accession Number:
0001209191-15-061694
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-20 17:02:27
Reporting Period:
2015-07-17
Filing Date:
2015-07-20
Accepted Time:
2015-07-20 17:02:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1117480 Chimerix Inc CMRX Pharmaceutical Preparations (2834) 330903395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1571865 W. Timothy Trost C/O Chimerix, Inc.
2505 Meridian Parkway, Suite 340
Durham NC 27713
Svp, Cfo & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-07-17 28,000 $2.35 37,850 No 4 M Direct
Common Stock Disposition 2015-07-17 28,000 $50.00 9,850 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2015-07-17 28,000 $0.00 28,000 $2.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
78,461 2021-04-06 No 4 M Direct
Footnotes
  1. Includes 678 shares of Common Stock that were acquired by the Reporting Person on March 10, 2015 pursuant to the Issuer's Employee Stock Purchase Plan.
  2. The sales reported in the Form 4 were effected pursuant to a Rule 10B5-1 Plan adopted by the reporting person on September 5, 2013.
  3. In accordance with its terms, the shares underlying the option are subject to vesting as follows: 1/4th of the shares vest one year after July 26, 2010; the remainder of the shares vest in equal monthly installments thereafter over the next three years.